Download presentation
Presentation is loading. Please wait.
Published byCarmella Bryan Modified over 9 years ago
1
Ensuring Safety in Public Health Programs RaPID Pharmacovigilance Program Safety First Paul Lalvani, Pharmacist, MBA, Executive Director O3i, RBM Board Meeting Nov 10-12
2
Recommended Target by UMC/WHO Country % of Target Achieved In collecting ADR reports Percent of Target Achieved in Collecting ADR Reports Most countries are operating at 1% to 5% of target
3
RaPID Pilot Africa for Africa TANZANIA BURUNDI EQUATORIAL GUINEA ANGOLA REP OF THE CONGO Libreville Kananga Ndola Nacala Dar es Salaam Zanzibar Mombasa Beira Kalemie Antananarivo Maputo Lusaka Bulawayo Harare Gaborone Johannesburg Durban Port Elizabeth Maseru Mbabane Cape Town Luderitz SOUTH AFRICA Walvis Bay Windhoek Namibe Menongue Lobito Malanje Lilongwe Mbeya Lake Tanganyika Nyasa MALAWI ZAMBIA MOZAMBIQUE MADAGASCAR ZIMBABWE BOTSWANA SWAZILAND Indian Ocean Indian Ocean LESOTHO SOUTH AFRICA Luanda NAMIBIA ANGOLA Kinshasa Brazzaville Pointe-Noire Toliara Pretoria Agadez Zinder NIGER CHAD Faya-Largeau N' Djamena Maiduguri Kano Abuja Red Sea SUDAN ETHIOPIA Khartoum Al Fashir Juba Waw Asmara Addis Ababa Port Sudan DJIBOUTI ERITREA UGANDA SOMALIA KENYA DEMOCRATIC REPUBLIC OF THE CONGO (ZAIRE) CENTRAL AFRICAN REPUBLIC RWANDA GABON NIGERIA Malabo Yaounde Bangui CAMEROON Djibouti Berbera Mogadishu Kisangani Bujumbura Nairobi Kampala Lake Victoria Kigali Bechar Tripoli Al Jawt Oran Algiers Tunis Cairo Aswan Constantine Rabat Marrakech Casablanca El Aaiun Lombouctou Nema Nouakchott Tamanrasset TUNISIA MOROCCO WESTERN SAHARA ALGERIA MALI LIBYA Niamey Bamako Mediterranean Sea EGYPT Alexandria Banghazi BENIN TOGO COTE DTVOIRE BURKINA GUINEA SENEGAL GHANA LIBERIA Abidjan Accra Loma Porto-Novo Ouagadougou Lagos MAURITANIA Dakar SIERRA LEONE GAMBIA GUINEA BISSAU Monrovia Freetown Banjul THE Conakry Bissau Aggregate data Preliminary QC
4
1 2 3 CLINIRX MH UNIV Data entry Causality assessment Expectedness Severity QC 4 Africa Asia America
5
Africa to Uppsala 5 Update global Vigiflow database
6
Safety Benefits of Pharmacovigilance—beyond Safety QualityResistance Improves Quality of Care Improves Compliance Reduces Drop Out Rates
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.